false0001823033Q1--12-31New YorkNY10281 0001823033 2022-01-01 2022-03-31 0001823033 2021-01-01 2021-03-31 0001823033 2022-03-31 0001823033 2021-12-31 0001823033 2021-01-01 2021-12-31 0001823033 2021-01-28 0001823033 2021-06-30 0001823033 2021-01-28 2021-01-28 0001823033 2021-03-31 0001823033 2021-04-13 2021-04-13 0001823033 2021-04-13 0001823033 2020-12-31 0001823033 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueInputsLevel1Member 2022-03-31 0001823033 us-gaap:CommonClassAMember 2022-03-31 0001823033 hcii:PrivatePlacementWarrantsMember 2022-03-31 0001823033 us-gaap:IPOMember 2022-03-31 0001823033 us-gaap:MoneyMarketFundsMember us-gaap:USTreasurySecuritiesMember 2022-03-31 0001823033 hcii:PublicWarrantMember us-gaap:CommonClassAMember 2022-03-31 0001823033 us-gaap:CommonClassBMember 2022-03-31 0001823033 srt:MinimumMember hcii:SponsorMember us-gaap:CommonClassAMember 2022-03-31 0001823033 hcii:WorkingCapitalLoansMember 2022-03-31 0001823033 hcii:ForwardPurchaseAgreementMember hcii:HecMasterFundLpMember 2022-03-31 0001823033 hcii:WorkingCapitalLoansMember hcii:SponsorMember 2022-03-31 0001823033 hcii:PublicWarrantsMember 2022-03-31 0001823033 us-gaap:CommonClassAMember hcii:BusinessCombinationMember 2022-03-31 0001823033 us-gaap:FairValueInputsLevel1Member hcii:PublicWarrantMember us-gaap:FairValueMeasurementsRecurringMember 2022-03-31 0001823033 hcii:PrivatePlacementWarrantMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2022-03-31 0001823033 us-gaap:FairValueInputsLevel3Member hcii:MeasurementInputForwardPurchasePriceMember 2022-03-31 0001823033 us-gaap:FairValueInputsLevel3Member hcii:MeasurementInputUnderlyingAssetPriceMember 2022-03-31 0001823033 us-gaap:FairValueInputsLevel3Member hcii:MeasurementInputNumberOfWarrantsMember 2022-03-31 0001823033 us-gaap:FairValueInputsLevel3Member hcii:MeasurementInputConcludedUnitValueMember 2022-03-31 0001823033 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputMaturityMember 2022-03-31 0001823033 hcii:PrivatePlacementWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:FairValueInputsLevel3Member 2022-03-31 0001823033 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-03-31 0001823033 hcii:PrivatePlacementWarrantsMember 2022-03-31 0001823033 us-gaap:CommonClassAMember 2021-12-31 0001823033 us-gaap:USTreasurySecuritiesMember us-gaap:MoneyMarketFundsMember 2021-12-31 0001823033 us-gaap:CommonClassBMember 2021-12-31 0001823033 us-gaap:FairValueInputsLevel1Member hcii:PublicWarrantMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001823033 hcii:PrivatePlacementWarrantMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001823033 us-gaap:FairValueInputsLevel3Member hcii:MeasurementInputForwardPurchasePriceMember 2021-12-31 0001823033 us-gaap:FairValueInputsLevel3Member hcii:MeasurementInputUnderlyingAssetPriceMember 2021-12-31 0001823033 us-gaap:FairValueInputsLevel3Member hcii:MeasurementInputNumberOfWarrantsMember 2021-12-31 0001823033 us-gaap:FairValueInputsLevel3Member hcii:MeasurementInputConcludedUnitValueMember 2021-12-31 0001823033 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputMaturityMember 2021-12-31 0001823033 hcii:PrivatePlacementWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001823033 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001823033 hcii:PublicWarrantsMember 2021-12-31 0001823033 hcii:PrivatePlacementWarrantsMember 2021-12-31 0001823033 hcii:PrivatePlacementWarrantsMember 2022-01-01 2022-03-31 0001823033 us-gaap:WarrantMember 2022-01-01 2022-03-31 0001823033 us-gaap:CommonClassAMember us-gaap:IPOMember 2022-01-01 2022-03-31 0001823033 us-gaap:CommonClassAMember us-gaap:OverAllotmentOptionMember 2022-01-01 2022-03-31 0001823033 us-gaap:CommonClassAMember 2022-01-01 2022-03-31 0001823033 us-gaap:CommonClassBMember 2022-01-01 2022-03-31 0001823033 srt:MinimumMember hcii:SponsorMember us-gaap:CommonClassAMember 2022-01-01 2022-03-31 0001823033 us-gaap:CommonClassAMember hcii:SponsorMember 2022-01-01 2022-03-31 0001823033 us-gaap:CommonClassAMember hcii:PublicWarrantMember 2022-01-01 2022-03-31 0001823033 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001823033 us-gaap:CommonClassBMember hcii:FounderMember 2022-01-01 2022-03-31 0001823033 hcii:AdministrativeSupportAgreementMember hcii:SponsorMember 2022-01-01 2022-03-31 0001823033 us-gaap:AccruedLiabilitiesMember 2022-01-01 2022-03-31 0001823033 hcii:PublicWarrantsMember srt:MinimumMember 2022-01-01 2022-03-31 0001823033 srt:MaximumMember hcii:PublicWarrantsMember 2022-01-01 2022-03-31 0001823033 hcii:PublicWarrantsMember 2022-01-01 2022-03-31 0001823033 hcii:PrivatePlacementWarrantMember us-gaap:WarrantMember 2022-01-01 2022-03-31 0001823033 hcii:PublicWarrantMember us-gaap:WarrantMember 2022-01-01 2022-03-31 0001823033 us-gaap:WarrantMember 2022-01-01 2022-03-31 0001823033 hcii:FpaDerivativeMember 2022-01-01 2022-03-31 0001823033 us-gaap:CapitalUnitsMember 2022-01-01 2022-03-31 0001823033 us-gaap:WarrantMember 2022-01-01 2022-03-31 0001823033 hcii:PrivatePlacementWarrantMember us-gaap:WarrantMember 2021-01-01 2021-03-31 0001823033 hcii:PublicWarrantMember us-gaap:WarrantMember 2021-01-01 2021-03-31 0001823033 us-gaap:WarrantMember 2021-01-01 2021-03-31 0001823033 hcii:FpaDerivativeMember 2021-01-01 2021-03-31 0001823033 us-gaap:CommonClassAMember 2021-01-01 2021-03-31 0001823033 us-gaap:CommonClassBMember 2021-01-01 2021-03-31 0001823033 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001823033 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001823033 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2021-01-01 2021-03-31 0001823033 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001823033 hcii:SponsorMember hcii:AdministrativeSupportAgreementMember 2021-01-01 2021-03-31 0001823033 us-gaap:CommonClassAMember us-gaap:IPOMember 2021-01-28 2021-01-28 0001823033 us-gaap:CommonClassAMember us-gaap:OverAllotmentOptionMember 2021-01-28 2021-01-28 0001823033 us-gaap:PrivatePlacementMember 2021-01-28 2021-01-28 0001823033 us-gaap:IPOMember 2021-01-28 2021-01-28 0001823033 us-gaap:CommonClassAMember us-gaap:IPOMember 2021-01-28 0001823033 us-gaap:PrivatePlacementMember 2021-01-28 0001823033 us-gaap:IPOMember 2021-01-28 0001823033 hcii:WorkingCapitalLoansMember hcii:SponsorMember 2021-01-28 0001823033 hcii:SponsorMember 2020-08-21 2020-08-21 0001823033 us-gaap:CommonClassBMember hcii:SponsorMember 2020-08-21 2020-08-21 0001823033 us-gaap:CommonClassBMember hcii:FounderMember 2020-12-18 2020-12-18 0001823033 us-gaap:CommonClassBMember hcii:FounderMember 2020-12-18 0001823033 hcii:AdministrativeSupportAgreementMember 2021-01-25 2021-01-25 0001823033 us-gaap:CommonClassBMember hcii:FounderMember 2021-01-25 2021-01-25 0001823033 us-gaap:CommonClassBMember hcii:FounderMember 2021-01-25 0001823033 us-gaap:CommonClassBMember hcii:FounderMember 2021-03-11 2021-03-11 0001823033 hcii:FounderMember 2021-04-13 2021-04-13 0001823033 hcii:FounderMember srt:DirectorMember 2021-04-13 2021-04-13 0001823033 hcii:FounderMember 2021-04-13 0001823033 hcii:FounderMember srt:DirectorMember 2022-02-07 2022-02-07 0001823033 us-gaap:OverAllotmentOptionMember 2021-01-26 2021-01-26 0001823033 us-gaap:OverAllotmentOptionMember 2021-01-26 0001823033 us-gaap:AccruedLiabilitiesMember 2021-01-01 2021-12-31 0001823033 us-gaap:CommonClassAMember 2021-01-01 2021-12-31 0001823033 us-gaap:CommonClassAMember 2022-05-13 0001823033 us-gaap:CommonClassBMember 2022-05-13 0001823033 hcii:FpaDerivativeMember 2021-12-31 0001823033 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2021-12-31 0001823033 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2021-12-31 0001823033 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001823033 us-gaap:RetainedEarningsMember 2021-12-31 0001823033 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2022-03-31 0001823033 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-03-31 0001823033 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001823033 us-gaap:RetainedEarningsMember 2022-03-31 0001823033 hcii:PrivatePlacementWarrantMember us-gaap:WarrantMember 2022-03-31 0001823033 hcii:PublicWarrantMember us-gaap:WarrantMember 2022-03-31 0001823033 us-gaap:WarrantMember 2022-03-31 0001823033 hcii:FpaDerivativeMember 2022-03-31 0001823033 hcii:PrivatePlacementWarrantMember us-gaap:WarrantMember 2020-12-31 0001823033 hcii:PublicWarrantMember us-gaap:WarrantMember 2020-12-31 0001823033 us-gaap:WarrantMember 2020-12-31 0001823033 hcii:FpaDerivativeMember 2020-12-31 0001823033 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2020-12-31 0001823033 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2020-12-31 0001823033 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001823033 us-gaap:RetainedEarningsMember 2020-12-31 0001823033 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2021-03-31 0001823033 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2021-03-31 0001823033 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001823033 us-gaap:RetainedEarningsMember 2021-03-31 0001823033 hcii:PrivatePlacementWarrantMember us-gaap:WarrantMember 2021-03-31 0001823033 hcii:PublicWarrantMember us-gaap:WarrantMember 2021-03-31 0001823033 us-gaap:WarrantMember 2021-03-31 0001823033 hcii:FpaDerivativeMember 2021-03-31 iso4217:USD xbrli:shares xbrli:pure utr:Day utr:Month iso4217:USD xbrli:shares utr:D
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM
10-Q
 
 
(MARK ONE)
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarter ended March 31, 2022
 
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from
    
    
    
    
to
    
    
    
    
Commission file number:
001-39931
 
 
HUDSON EXECUTIVE INVESTMENT CORP. II
(Exact Name of Registrant as Specified in Its Charter)
 
 
 
Delaware
  
85-2658967
(State or other jurisdiction of
incorporation or organization)
  
(I.R.S. Employer
Identification No.)
Address not applicable
(1)
(Address of principal executive offices)
(212)
 
521-8495
(Issuer’s telephone number)
(Former name or former address of principal executive office, if changed since last report.)
N/A
 
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
  
Trading
Symbols
  
Name of each exchange
on which registered
Units, each consisting of one share of Class A common stock and
one-fourth
of one redeemable warrant
  
HCIIU
  
The Nasdaq Stock Market LLC
Class A common stock, par value $0.0001 per share
  
HCII
  
The Nasdaq Stock Market LLC
Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
  
HCIIW
  
The Nasdaq Stock Market LLC
Check whether the issuer (1)
 filed all reports required to be filed by Section
 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No
  
☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T
 
(
§
232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
    
Yes
  
☒
    
No
  
☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, anon-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule
12b-2
of the Exchange Act.
 
Large accelerated filer   ☐    Accelerated filer   ☐
       
Non-accelerated
filer		   ☒    Smaller reporting company   ☒
       
         Emerging growth company   ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange
Act).    Yes  ☒    No  ☐
As of May 13
, 2022, there were 25,000,000 shares of Class A common stock, $0.0001 par value and 6,250,000 shares of Class B common stock, $0.0001 par value, issued and outstanding.
 
(1)
In September 2021, the registrant became a fully remote company. Accordingly, it does not maintain a principal executive office.
 
 
 
HUDSON EXECUTIVE INVESTMENT CORP. II
FORM
10-Q
FOR THE QUARTER ENDED MARCH 31, 2022
TABLE OF CONTENTS
 
    
Page
  
Part I. Financial Information      1  
   
     1  
   
     1  
   
     2  
   
     3  
   
     4  
   
     5  
   
     18  
   
     21  
   
     21  
   
Part II. Other Information      22  
   
     22  
   
     22  
   
     22  
   
     22  
   
     22  
   
     22  
   
     23  
   
Part III. Signatures      24  
 
i
PART I. FINANCIAL INFORMATION
Item 1. Condensed Financial Statements.
HUDSON EXECUTIVE INVESTMENT CORP. II
CONDENSED BALANCE SHEETS

                 
    
March 31,

2022
    
December 31,

2021
  
    
(Unaudited)
        
ASSETS
                 
Current assets
                 
Cash
    $ 281,975     $ 829,503  
Prepaid expenses
      185,030       41,079  
    
 
 
    
 
 
  
Total Current Assets
      467,005       870,582  
Forward purchase agreement derivative asset
      124,000       51,625  
Marketable securities held in Trust Account
      250,076,625       250,035,428  
    
 
 
    
 
 
  
TOTAL ASSETS
   
$
250,667,630
 
  
$
250,957,635
 
    
 
 
    
 
 
  
LIABILITIES, CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS’ DEFICIT
                 
Current liabilities
                 
Accrued expenses
    $ 880,963     $ 739,042  
Accrued offering costs
      25,000       114,958  
Due to related party
      26,097       4,700  
    
 
 
    
 
 
  
Total Current Liabilities
      932,060       858,700  
Warrant liabilities
      4,081,742       7,315,259  
Deferred underwriting fee payable
      8,750,000       8,750,000  
    
 
 
    
 
 
  
Total Liabilities
   
 
13,763,802
 
  
 
16,923,959
 
    
 
 
    
 
 
  
Commitments and Contingencies
            
Class A common stock subject to possible redemption, $0.0001 par value, 25,000,000
shares at 
$10.00
per share redemption value March 31, 2022 and December 31, 2021
      250,000,000       250,000,000  
Stockholders’ Deficit
                 
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued or outstanding
      —         —    
Class A common stock, $0.0001 par value; 380,000,000 shares authorized; no shares issued and outstanding (excluding 25,000,000 shares subject to possible redemption) as of March 31, 2022 and December 31, 2021
      —         —    
Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 6,250,000 shares issued and outstanding as of March 31, 2022 and December 31, 2021
      625       625  
Additional
paid-in
capital
      —         —    
Accumulated deficit
      (13,096,797 )      (15,966,949 ) 
    
 
 
    
 
 
  
Total Stockholders’ Deficit
   
 
(13,096,172
) 
  
 
(15,966,324
) 
    
 
 
    
 
 
  
TOTAL LIABILITIES, CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS’ DEFICIT
   
$
250,667,630
 
  
$
250,957,635
 
    
 
 
    
 
 
  
The accompanying notes are an integral part of the unaudited condensed financial statements.
 
1
HUDSON EXECUTIVE INVESTMENT CORP. II
CONDENSED STATEMENTS OF OPERATIONS
(UNAUDITED)

                 
    
Three Months Ended

March 31,
  
    
2022
    
2021
  
Formation and operating costs
    $ 476,937     $ 1,038,176  
    
 
 
    
 
 
  
Loss from operations
   
 
(476,937
) 
  
 
(1,038,176
) 
    
 
 
    
 
 
  
Other income:
                 
Change in fair value of warrant liabilities and forward purchase agreement derivative asset
      3,305,892       4,709,975  
Interest earned on marketable securities held in Trust Account
      41,197       16,381  
    
 
 
    
 
 
  
Total other income
   
 
3,347,089
 
  
 
4,726,356
 
    
 
 
    
 
 
  
Net income
   
$
2,870,152
 
  
$
3,688,180
 
    
 
 
    
 
 
  
Weighted average shares outstanding, Class A common stock
      25,000,000       17,222,222  
    
 
 
    
 
 
  
Basic and diluted net income per share, Class A common stock
   
$
0.09
 
  
$
0.16
 
    
 
 
    
 
 
  
Weighted average shares outstanding, Class B common stock
      6,250,000       6,055,556  
    
 
 
    
 
 
  
Basic net income per share, Class B common stock
   
$
0.09
 
  
$
0.16
 
    
 
 
    
 
 
  
Weighted average shares outstanding, Class B common stock
      6,250,000       6,250,000  
    
 
 
    
 
 
  
Diluted net income per share, Class B common stock
   
$
0.09
 
  
$
0.16
 
    
 
 
    
 
 
  
The accompanying notes are an integral part of the unaudited condensed financial statements.
 
2
HUDSON EXECUTIVE INVESTMENT CORP. II
CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)
(UNAUDITED)
THREE MONTHS ENDED MARCH 31, 2022
 
     
            
      
            
      
            
      
            
      
            
      
            
      
            
  
    
Class A

Common Stock
     
Class B

Common Stock
     
Additional

Paid-in

Capital
     
Accumulated

Deficit
    
Total

Stockholders’

Deficit
  
    
Shares
     
Amount
     
Shares
     
Amount
                      
Balance — January 1, 2022
   
 
—  
 
   
$
—  
     
 
6,250,000
 
   
$
625
 
   
$
—  
     
$
(15,966,949
) 
  
$
(15,966,324
) 
Net income
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
—  
 
   
 
2,870,152
 
  
 
2,870,152
 
    
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
    
 
 
  
Balance – March 31, 2022
 (unaudited)
   
 
—  
 
   
$
—  
     
 
6,250,000
 
   
$
625
 
   
$
—  
     
$
(13,096,797
) 
  
$
(13,096,172
) 
    
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
    
 
 
  
THREE MONTHS ENDED MARCH 31, 2021

                                                         
    
Class A

Common Stock
     
Class B

Common Stock
    
Additional

Paid-in

Capital
    
Accumulated

Deficit
    
Total

Stockholders’

Equity (Deficit)
  
    
Shares
     
Amount
     
Shares
    
Amount
                    
Balance — January 1, 2021
   
 
—  
 
   
$
—  
     
 
6,468,750
 
  
$
647
 
  
$
24,353
 
  
$
(1,268
) 
  
$
23,732
 
Excess of proceeds from the sale of Private Placement Warrants to Sponsor
      —          —          —         —         1,282,400       —         1,282,400  
Forfeiture of Founder Shares
      —          —          (218,750 )      (22 )      22       —         —    
Accretion for Class A common stock to redemption value
      —          —          —         —         (1,306,775 )      (20,072,673 )      (21,379,448 ) 
Net income
      —          —          —         —         —         3,688,180       3,688,180  
    
 
 
     
 
 
     
 
 
    
 
 
    
 
 
    
 
 
    
 
 
  
Balance – March 31, 2021
 (unaudited)
   
 
—  
 
   
$
—  
     
 
6,250,000
 
  
$
625
 
  
$
—  
 
  
$
(16,385,761
) 
  
$
(16,385,136
) 
    
 
 
     
 
 
     
 
 
    
 
 
    
 
 
    
 
 
    
 
 
  
The accompanying notes are an integral part of the unaudited condensed financial statements.
 
3
HUDSON EXECUTIVE INVESTMENT CORP. II
CONDENSED STATEMENTS OF CASH FLOWS
(UNAUDITED)

                 
    
Three Months

Ended

March 31,

2022
    
Three Months
Ended

March 31,

2021
  
Cash Flows from Operating Activities:
                 
Net income
    $ 2,870,152     $ 3,688,180  
Adjustments to reconcile net income to net cash used in operating activities:
                 
Operating costs paid by Sponsor
      —         200  
Operating costs paid through promissory note
      —         70,764  
Change in fair value of warrant liabilities and forward purchase agreement derivative asset
      (3,305,892 )      (4,709,975 ) 
Transaction costs incurred in connection with warrant liabilities
      —         442,366  
Interest earned on marketable securities held in Trust Account
      (41,197 )      (16,381 ) 
Changes in operating assets and liabilities:
                 
Prepaid expenses
      (143,951 )      (453,689 ) 
Due to related party
      21,397       —    
Accrued expenses
      51,963       410,292  
    
 
 
    
 
 
  
Net cash used in operating activities
   
 
(547,528
) 
  
 
(568,243
) 
    
 
 
    
 
 
  
Cash Flows from Investing Activities:
                 
Investment of cash in Trust Account
      —         (250,000,000 ) 
    
 
 
    
 
 
  
Net cash used in investing activities
   
 
—  
 
  
 
(250,000,000
) 
    
 
 
    
 
 
  
Cash Flows from Financing Activities
                 
Proceeds from sale of Units, net of underwriting discounts paid
      —         245,000,000  
Proceeds from sale of Private Placements Warrants
      —         7,000,000  
Due from Sponsor
      —         (132,376 ) 
Repayment of promissory note—related party
      —         (94,922 ) 
Payment of offering costs
      —         (315,207 ) 
    
 
 
    
 
 
  
Net cash provided by financing activities
   
 
—  
 
  
 
251,457,495
 
    
 
 
    
 
 
  
Net Change in Cash
   
 
(547,528
) 
  
 
889,252
 
Cash – Beginning of period
      829,503       185  
    
 
 
    
 
 
  
Cash – End of period
   
$
281,975
 
  
$
889,437
 
    
 
 
    
 
 
  
Non-Cash
investing and financing activities:
                 
Offering costs included in accrued offering costs
    $ —       $ (229,072 ) 
    
 
 
    
 
 
  
Offering costs paid through promissory note
    $ —       $ 7,449  
    
 
 
    
 
 
  
Payment of prepaid expenses through promissory note
    $ —       $ 8,483  
    
 
 
    
 
 
  
Accretion for Class A common stock to redemption amount
    $ —       $ 21,379,448  
    
 
 
    
 
 
  
Deferred underwriting fee payable
    $ —       $ 8,750,000  
    
 
 
    
 
 
  
The accompanying notes are an integral part of the unaudited condensed financial statements.
 
4
HUDSON EXECUTIVE INVESTMENT CORP. II
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2022
(Unaudited)
NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Hudson Executive Investment Corp. II (formerly Hudson Executive Investment Corp. III) (the “Company”) is a blank check company incorporated in Delaware on August 18, 2020. On December 18, 2020, Hudson Executive Investment Corp. III filed a certificate of amendment changing its name from Hudson Executive Investment Corp. III to Hudson Executive Investment Corp. II. The Company was formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”).
The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.
As of March 31, 2022, the Company had not commenced any operations. All activity for the period from August 18, 2020 (inception) through March 31, 2022 relates to the Company’s formation, the initial public offering (the “Initial Public Offering”), which is described below, and identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates
non-operating
income in the form of interest income from the marketable securities held in the Trust Account (as defined below).
The registration statement for the Company’s Initial Public Offering was declared effective on January 25, 2021. On January 28, 2021
,
the Company consummated the Initial Public Offering of 25,000,000 units (the “Units” and, with respect to the Class A common stock included in the Units sold, the “Public Shares”), which includes the partial exercise by the underwriter of its over-allotment option in the amount of 2,500,000 Units, at $10.00 per Unit, generating gross proceeds of $250,000,000 which is described in Note 3.
Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 4,666,667 warrants (the “Private Placement Warrants”) at a price of $1.50 per Private Placement Warrant in a private placement to HEC Sponsor II LLC (formerly HEC Sponsor III LLC) (the “Sponsor”), generating gross proceeds of $7,000,000, which is described in Note 4.
Transaction costs amounted to $14,238,064, consisting of $5,000,000 in cash underwriting fees, net of reimbursement, $8,750,000 of deferred underwriting fees and $488,064 of other offering costs.
Following the closing of the Initial Public Offering on January 28, 2021, an amount of $250,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”), located in the United States and invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of
Rule 2a-7
of the Investment Company Act of 1940, as amended (the “Investment Company Act”), as determined by the Company, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the funds held in the Trust Account, as described below.
The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete a Business Combination with one or more target businesses that together have an aggregate fair market value of at least 80% of the value of the Trust Account (excluding the deferred underwriting commissions and taxes payable on income earned on the Trust Account) at the time of the agreement to enter into an initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.
 
5
HUDSON EXECUTIVE INVESTMENT CORP. II
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2022
(Unaudited)
 
The Company will provide its holders of the outstanding Public Shares (the “public stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants.
The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 either prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or do not vote at all.
Notwithstanding the foregoing, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Certificate of Incorporation provides that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 20% of the Public Shares, without the prior consent of the Company.
The Sponsor has agreed (a) to waive its redemption rights with respect to its Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Certificate of Incorporation (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination or (ii) with respect to any other provision relating to stockholders’ rights or
pre-initial
business combination activity, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.
The Company will have until January 28, 2023 to complete a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at
a per-share
price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.
 
6
HUDSON EXECUTIVE INVESTMENT CORP. II
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2022
(Unaudited)
 
The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00).
In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (1) $10.00 per Public Share and (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held in the Trust Account nor will it apply to any under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors (other than the independent registered public accounting firm), service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
Liquidity and Going Concern
As of March 31, 2022, the Company had $281,975 in its operating bank account and
a
working capital deficit of $388,430
. In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsors or an affiliate of the Sponsors, or certain of the Company’s officers and directors, may provide the Company with Working Capital Loans (as defined below) (see Note 5).
The Company intends to complete a Business Combination by January 28, 2023. However, in the absence of a completed Business Combination, the Company may require additional capital. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, suspending the pursuit of a Business Combination. The Company cannot provide any assurance that new f
i
nancing will be available to it on commercially acceptable terms, if at all.
In connection with the Company’s assessment of going concern
considerations
in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”)
2014-15,
“Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that if the Company is unable to complete a Business Combination by January 28, 2023, then the Company will cease all operations except for the purpose of liquidating. The date for mandatory liquidation and subsequent dissolution as well as a lack of liquidity raise substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after January 28, 2023.
NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to
Form 10-Q and
Article 8 of
Regulation S-X
of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.
The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form
10-K
for the year ended December 31, 2021 as filed with the SEC on March 31, 2022. The interim results for the three months ended March 31, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or for any future periods.
Emerging Growth Company
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.
 
7
HUDSON EXECUTIVE INVESTMENT CORP. II
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2022
(Unaudited)
 
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates
The preparation of the condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of revenues and expenses during the reporting periods.
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liabilities and forward purchase agreement (“FPA”) (as described in Note 9). Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of March 31, 2022 and December 31, 2021.
Class A Common Stock Subject to Possible Redemption
The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A common stock subject to mandatory redemption, if any, are classified as a liability instrument and is measured at redemption value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at March 31, 2022 and December 31, 2021, 25,000,000 shares of Class A common shares subject to possible redemption are presented as temporary equity, outside of the stockholders’ deficit section of the Company’s condensed balance sheets.
The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock, if any, are affected by charges against additional paid in capital and accumulated deficit.
At March 31, 2022 and December 31, 2021, the Class A common stock reflected in the condensed balance sheets are reconciled in the following table:
         
Gross proceeds
    $ 250,000,000  
Less:
         
Proceeds allocated to Public Warrants
      (7,583,750 ) 
Class A common stock issuance costs
      (13,795,698 ) 
Plus:
         
Accretion of carrying value to redemption value
      21,379,448  
    
 
 
  
Class A common stock subject to possible redemption
    $ 250,000,000  
    
 
 
  
 
8
HUDSON EXECUTIVE INVESTMENT CORP. II
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2022
(Unaudited)
 
Offering Costs
Offering costs consisted of legal, accounting, and other expenses incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs allocated to warrant liabilities were expensed as incurred in the condensed statements of operations.
Offering costs associated with the Class A common stock issued the amount of $14,238,064 were charged against the carrying value of the Class A common stock subject to possible redemption upon the completion of the Initial Public Offering. Offering costs amounting to $442,366 were charged to the statements of operations upon the completion of the Initial Public Offering (see Note 1).
Warrant Liabilities and Forward Purchase Agreement Derivative Asset
The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and Financial Accounting Standards Board (“FASB”) ASC Topic 815, “Derivatives and Hedging” (“ASC 815”).
The Company accounts for the Public Warrants (as defined in Note 3) and the Private Placement Warrants (collectively, the “Warrants”) and FPA in accordance with the guidance contained in ASC
815-40,
under which the Warrants and Forward Purchase Agreement (as described in Note 5) do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Warrants and FPA as assets or liabilities at their fair value and adjust the Warrants and FPA to fair value at each reporting period. These assets or liabilities are subject to
re-measurement
at each balance sheet date until exercised, and any change in fair value is recognized in the statements of operations. The fair value of the Public Warrants and the Private Placement Warrants has been estimated using the Public Warrants’ quoted market price. The FPA’s fair value was estimated using the reconstructed unit price, the net present value of per forward purchase unit commitment, and the forward purchase unit.
Income Taxes
The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. As of March 31, 2022 and December 31, 2021, the Company had a deferred tax asset of approximately $404,000 and $313,000, which had a full valuation allowance recorded against it, respectively.
The Company’s general and administrative costs are generally considered
start-up
costs and are not currently deductible. The change in fair value of the warrant liability is a permanent difference. During the three months ended March 31, 2022 and 2021, the Company recorded no income tax expense. The Company’s effective tax rate for three months ended March 31, 2022 and 2021 was approximately 0%, which differs from the expected income tax rate due to the
start-up
costs (discussed above) which are not currently deductible, permanent differences and a valuation allowance
ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.
Net Income per Common Share
The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income per common share is computed by dividing net income by the weighted average number of common shares outstanding for the period. Accretion associated with the redeemable shares of Class A common stock is excluded from income per common share as the redemption value approximates fair value.
 
9
HUDSON EXECUTIVE INVESTMENT CORP. II
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2022
(Unaudited)
 
The calculation of diluted income per common share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 10,916,667 shares of Class A common stock in the aggregate. As of March 31, 2022 and 2021, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net income per common share is the same as basic net income per common share for the periods presented.
The following table reflects the calculation of basic and diluted net income per common share (in dollars, except per share amounts):
                                 
    
Three Months Ended

March 31, 2022
     
Three Months Ended

March 31, 2021
  
    
Class A
     
Class B
     
Class A
     
Class B
  
Basic net income per common share
                                    
Numerator:
                                    
Allocation of net income, as adjusted
    $ 2,296,122      $ 574,030      $ 2,728,725      $ 959,455  
Denominator:
                                    
Basic weighted average shares outstanding
      25,000,000        6,250,000        17,222,222        6,055,556  
Basic net income per common share
    $ 0.09      $ 0.09      $ 0.16      $ 0.16  
                                 
    
Three Months Ended

March 31, 2022
     
Three Months Ended

March 31, 2021
  
    
Class A
     
Class B
     
Class A
     
Class B
  
Diluted net income per common share
                                    
Numerator:
                                    
Allocation of net income, as adjusted
    $ 2,296,122      $ 574,030      $ 2,706,120      $ 982,060  
Denominator:
                                    
Diluted weighted average shares outstanding
      25,000,000        6,250,000        17,222,222        6,250,000  
Diluted net income per common share
    $ 0.09      $ 0.09      $ 0.16      $ 0.16  
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such account.
Fair Value of Financial Instruments
The fair value of the Company’s assets and liabilities which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximate the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature other than the warrant liabilities and FPA (see Note 9).
Recent Accounting Standards
Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements.
 
10
HUDSON EXECUTIVE INVESTMENT CORP. II
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2022
(Unaudited)
 
NOTE 3. PUBLIC OFFERING
Pursuant to the Initial Public Offering, the Company sold 25,000,000 Units, which includes a partial exercise by the underwriters of their over-allotment option in the amount of 2,500,000 Units, at a price of $10.00 per Unit. Each Unit consists of one share of Class A common stock and
one-fourth
of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 8).
NOTE 4. PRIVATE PLACEMENT
Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 4,666,667 Private Placement Warrants at a price of $1.50 per Private Placement Warrant the Company in a private placement that occurred simultaneously with the closing of the Initial Public Offering. Each Private Placement Warrant is exercisable to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 8). A portion of the proceeds from the Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Placement Warrants will expire worthless.
NOTE 5. RELATED PARTY TRANSACTIONS
Founder Shares
On August 21, 2020, the Sponsor paid $25,000 to cover certain offering costs of the Company in consideration of 2,875,000 shares of the Company’s Class B common stock (the “Founder Shares”). On December 18, 2020, the Company effected a 2,875,000 stock dividend resulting in 5,750,000 Founder Shares outstanding and on January 25, 2021, the Company effected a 718,750 stock dividend resulting in 6,468,750 Founder Shares outstanding. The Founder Shares included an aggregate of up to 218,750 shares of Class B common stock that were subject to forfeiture by the Sponsor. On March 11, 2021, the above-mentioned 218,750 shares of Class B common stock were forfeited following the expiration of the underwriters’ overallotment option.
The Sponsor has agreed, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of (A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) if the closing price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within
any 30-trading
day period commencing at least 150 days after a Business Combination, or (y) the date following the completion of a Business Combination on which the Company completes a liquidation, merger, stock exchange, reorganization or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of Class A common stock for cash, securities or other property.
On April 13, 2021, the Company added a new member to the sponsorship and the Sponsor allocated 20,000 Founder Shares. The total consideration paid for these shares was $58. In addition, on April 13, 2021, the Sponsor also transferred 20,000 Founder Shares to a director of the Company. Finally, on February 7, 2022, the sponsor transferred 20,000 Founder Shares to a newly appointed director of the Company.
The sale and allocation of the Founders Shares to the Company’s director nominees as described above, is within the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The fair value of the 40,000 shares allocated on April 13, 2021 was $299,880 or $7.50
 
per share. The Founders Shares were effectively sold subject to a performance condition (i.e., the occurrence of a Business Combination). Compensation expense related to the Founders Shares is recognized only when the performance condition is probable of occurrence under the applicable accounting literature in this circumstance. Stock-based compensation would be recognized at the date a Business Combination is considered probable in an amount equal to the number of Founders Shares times the grant date fair value per share (unless subsequently modified) less the amount initially received for the purchase of the Founders Shares. As of March 31, 2022, no stock-based compensation expense has been
recorded
.
On February 7, 2022, the Board of Directors exercised its authority pursuant to the Company’s amended and restated certificate of incorporation and elected Mr. Douglas Renert, effective immediately, to the Board of Directors. Mr. Renert replaced Mr. Douglas Braunstein on the Audit Committee, effective immediately. Mr. Renert is an independent director.
Administrative Services Agreement
The Company entered into an agreement, commencing on January 25, 2021 through the earlier of the Company’s consummation of a Business Combination or its liquidation, to pay an affiliate of the Sponsor a total of $10,000 per month for office space, secretarial and administrative services. For the three months ended March 31, 2022 and 2021, the Company incurred $30,000 and $20,000 in fees for these services, respectively. As of March 31, 2022 and December 31, 2021, the Company has recorded $140,000 and $110,000
, respectively, in its condensed balance sheets for amounts due.
 
11
HUDSON EXECUTIVE INVESTMENT CORP. II
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2022
(Unaudited)
 
Due from Sponsor
At the closing of the Initial Public Offering on January 28, 2021, a portion of the proceeds from the sale of the Private Placement Warrants in the amount of $150,000
was due to the Company to be held outside of the Trust Account for working capital purposes. As of March 31, 2022 and December 31, 2021, such amount was repaid
and is no longer due from the Sponsor. The Company can no longer borrow from this note.
Related Party Loans
In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor, an affiliate of the Sponsor, or certain of the Company’s officers and directors or their affiliates may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.50 per warrant at the option of the lender. The warrants would be identical to the Private Placement Warrants. As of March 31, 2022 and December 31, 2021, there were no Working Capital Loans outstanding.
Due to Related Party
From time to time, the Sponsor or an affiliate of the Sponsor will make payments on behalf of the Company for operating expenses that may include annual or quarterly subscriptions. At March 31, 2022 and December 31, 2021, the amount owed amounted to $26,097 and $4,700, respectively.
Forward Purchase Agreement
Following the Initial Public Offering on January 28, 2021, the Company entered into a forward purchase agreement dated January 28, 2021 with HEC Master Fund LP (“HEC Master”) pursuant to which HEC Master will purchase from the Company up to 5,000,000 forward purchase units (the “Forward Purchase Units”), consisting of one share of Class A common stock (the “Forward Purchase Shares”) and a mutually agreed upon number of warrants to purchase one share of Class A common stock (the “Forward Purchase Warrants” and, together with the Forward Purchase Shares, the “Forward Purchase Securities”),for $10.00 per unit, in a private placement that will close concurrently with the closing of the initial Business Combination. The proceeds from the sale of these Forward Purchase Units, together with the amounts available to the Company from the Trust Account (after giving effect to any redemptions of Public Shares) and any other equity or debt financing obtained by the Company in connection with the Business Combination, will be used to satisfy the cash requirements of the Business Combination, including funding the purchase price and paying expenses and retaining specified amounts to be used by the post-Business Combination company for working capital or other purposes. To the extent that the amounts available from the Trust Account and other financing are sufficient for such cash requirements, HEC Master may purchase less than an agreed upon number of Forward Purchase Units. In addition, HEC Master’s commitment under the forward purchase agreement will be subject to approval, prior to the Company entering into a definitive agreement for the initial Business Combination, of its investment committee. Pursuant to the terms of the Forward Purchase Agreement, HEC Master will have the option to assign its commitment to one of its affiliates and an agreed upon amount to members of the Company’s management team. The Forward Purchase Shares will be identical to the shares of Class A common stock included in the units sold in the Initial Public Offering, except that they will be subject to transfer restrictions and registration rights. The Forward Purchase Warrants will have the same terms as the Private Placement Warrants so long as they are held by HEC Master or its permitted assignees and transferees.
NOTE 6. COMMITMENTS AND CONTINGENCIES
Risks and Uncertainties
Management continues to evaluate the impact of the
COVID-19
pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these condensed financial statements. The condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.
In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Furthermore, the impact of this action and related sanctions on the world economy are not determinable as of the date of these condensed financial statements, and the specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these condensed financial statements.
 
12
HUDSON EXECUTIVE INVESTMENT CORP. II
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2022
(Unaudited)
 
Registration Rights
Pursuant to a registration rights agreement entered into on January 28, 2021, the holders of the Founder Shares, Private Placement Warrants, Forward Purchase Securities and warrants that may be issued upon conversion of Working Capital Loans (and any Class A common stock issuable upon the exercise of the Private Placement Warrants, Forward Purchase Warrants and warrants issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares) will be entitled to registration rights pursuant to a registration rights agreement requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to shares of Class A common stock). The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders will have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. The registration rights agreement does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriting Agreement
The Company granted the underwriters
a 45-day option
from the date of the Initial Public Offering to purchase up to 3,000,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. As a result of the underwriter’s election to partially exercise the over-allotment option to purchase an additional 2,500,000 Units, a total of 875,000 Units remained available for purchase at a price of $10.00 per Unit. On March 11, 2021, the remainder of the underwriters’ overallotment option expired.
The underwriters are entitled to a deferred fee of $0.35 per Unit, or $8,750,000 in the aggregate. The deferred fee will be forfeited by the underwriters solely in the event that the Company fails to complete a Business Combination, subject to the terms of the underwriting agreement.
NOTE 7. STOCKHOLDERS’ DEFICIT
Preferred Stock
—
The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of March 31, 2022 and December 31, 2021, there were no shares of preferred stock issued or outstanding.
Class
 A Common Stock
— The Company is authorized to issue 380,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of Class A common stock are entitled to one vote for each share. As of March 31, 2022 and December 31, 2021, there were no shares issued and outstanding, excluding 25,000,000 shares of Class A common stock subject to possible redemption, which are classified as temporary equity.
The Company determined the common stock subject to redemption to be equal to the redemption value of $10.00 per share of common stock while also taking into consideration a redemption cannot result in net tangible assets being less than $5,000,001. Upon considering the impact of the Forward Purchase Agreement, it was concluded that the redemption value should include all the Public Shares resulting in the common stock subject to possible redemption being equal to $250,000,000. This resulted in a measurement adjustment to the initial carrying value of the Class A common stock subject to redemption with the offset recorded to additional
paid-in
capital and accumulated deficit.
Class
 B Common Stock
— The Company is authorized to issue 20,000,000 shares of Class B common stock with a par value of $0.0001 per share. Holders of Class B common stock are entitled to one vote for each share. As of March 31, 2022 and December 31, 2021, there were 6,250,000 shares of Class B common stock issued and outstanding.
Holders of Class A common stock and Class B common stock will vote together as a single class on all matters submitted to a vote of stockholders except as required by law.
The shares of Class B common stock will automatically convert into shares of Class A common stock concurrently with or immediately following the consummation of a Business Combination on a
one-for-one
basis, subject to adjustment. In the case that additional shares of Class A common stock or equity-linked securities are issued or deemed issued in connection with a Business Combination, the number of shares of Class A common stock issuable upon conversion of all Founder Shares will equal, in the aggregate, on an
as-converted
basis, 20% of the total number of shares of Class A common stock outstanding after such conversion, including the total number of shares of Class A common stock issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or
 
13
HUDSON EXECUTIVE INVESTMENT CORP. II
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2022
(Unaudited)
 
rights issued or deemed issued, by the Company in connection with or in relation to the consummation of a Business Combination (including the Forward Purchase Shares but not the Forward Purchase Warrants), excluding any shares of Class A common stock or equity-linked securities or rights exercisable for or convertible into shares of Class A common stock issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans, provided that such conversion of Founder Shares will never occur on a less the
none-for-one
basis.
NOTE 8. WARRANT
LIABILITIES
Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable on the later of (a) 12 months from the closing of the Initial Public Offering and (b) 30 days after the completion of a Business Combination.
The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the Class A common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable, and the Company will not be obligated to issue a share of Class A common stock upon exercise of a warrant unless the share of Class A common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants.
The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of a Business Combination, it will use its commercially reasonable efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A common stock issuable upon exercise of the warrants. The Company will use its commercially reasonable efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants is not effective by the 60th business day after the closing of an initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption.
Notwithstanding the above, if the Class A common stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.
Once the warrants become exercisable, the Company may call the warrants for redemption:
 
  •  
in whole and not in part;
 
  •  
at a price of $0.01 per warrant;
 
  •  
upon not less than 30 days’ prior written notice of redemption to each warrant holder; and
 
  •  
if, and only if, the closing price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within
a 30-tradingday
period ending three business days before the Company sends the notice of redemption to the warrant holders.
 
14
HUDSON EXECUTIVE INVESTMENT CORP. II
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2022
(Unaudited)
 
If and when the warrants become redeemable by the Company for cash, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.
If the Company calls the Public Warrants for redemption for cash, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, except as described below, the warrants will not be adjusted for issuance of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.
In addition, if (x) the Company issues additional Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination (excluding any issuance of Forward Purchase Securities) at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Class A common stock during the 20 trading day period starting on the trading day after the day on which the Company consummates a Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.
At March 31, 2022 and December 31, 2021, there
we
re 4,666,667 Private
Placement
Warrants and 6,250,000 Public Warrants outstanding.
NOTE 9. FAIR VALUE MEASUREMENTS
The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
 
Level 1:  
Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
 
Level 2:  
Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
 
Level 3:  
Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.
The Company classifies its U.S. Treasury and equivalent securities as
held-to-maturity
in accordance with ASC Topic 320 “Investments—Debt and Equity Securities.”
Held-to-maturity
securities are those securities which the Company has the ability and intent to hold until maturity.
Held-to-maturity
treasury securities are recorded at amortized cost on the accompanying condensed balance sheets and adjusted for the amortization or accretion of premiums or discounts.
 
15
HUDSON EXECUTIVE INVESTMENT CORP. II
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2022
(Unaudited)
 
At March 31, 2022, assets held in the Trust Account were comprised
of $2,629 in cash and $
250,076,625
in U.S. Treasury Securities. During the three months ended March 31, 2022, the Company did
no
t withdraw any interest income from the Trust Account.
At December 31, 2021, assets held in the Trust Account were comprised of $250,035,428 in money market funds, which are invested primarily in U.S. Treasury Securities. During the year ended December 31, 2021, the Company did not withdraw any interest income from the Trust Account.
The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at March 31, 2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.
 
 
  
Held-To-Maturity
  
Level
 
  
Amortized

Cost
 
  
Gross
Holding
Loss
 
 
Fair Value
 
Assets:
  
  
  
  
 
March 31, 2022
    U.S. Treasury Securities (Mature on 6/16/2022)      1
 
  
$
 
250,073,996
 
 
$
(21,262 
)
 
 
 $ 250,052,734  
March 31, 2022
    FPA Derivativ
e
 Asset
      3
 
     
 
 
 
 
 
 
 
 $ 124,000  
December 31, 2021        
    Marketable Securities held in Trust Account –Treasury Trust Money Market Fund      1
 
     
 
 
 
 
 
 
 
 $ 250,035,428  
December 31, 2021
    FPA Derivative Asset      3
 
     
 
 
 
 
 
 
 
 $ 51,625  
Liabilities:
            
 
     
 
 
 
 
 
 
 
      
March 31, 2022
    Warrant Liability – Public Warrants      1
 
     
 
 
 
 
 
 
 
 $ 2,336,875  
March 31, 2022
    Warrant Liability – Private Placement Warrants      2
 
     
 
 
 
 
 
 
 
 $ 1,744,867  
December 31, 2021
    Warrant Liability – Public Warrants      1
 
     
 
 
 
 
 
 
 
 $ 4,188,125  
December 31, 2021
    Warrant Liability – Private Placement Warrants      2
 
     
 
 
 
 
 
 
 
 $ 3,127,134  
The Warrants and FPA were accounted for as assets or liabilities in accordance with ASC
815-40
and are presented within FPA derivative asset and warrant liabilities on the accompanying condensed balance sheets. The Warrants and FPA are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the change in fair value of warrant liabilities and FPA in the condensed statements of operations.
The Public Warrants were initially valued using a Monte Carlo simulation model. The Public Warrants were subsequently valued using the instrument’s publicly listed trading price as of the balance sheet date, which is considered to be a Level 1 measurement due to the use of an observable market quote in an active market.
The Private Placement Warrants were valued initially, using a Modified Black Scholes Model, which is considered to be a Level 3 fair value measurement. The primary significant unobservable input used in the fair value measurement of the Private Placement Warrants is the expected volatility of the common stock. Significant increases (decreases) in the expected volatility in isolation would result in a significantly higher (lower) fair value measurement. The subsequent measurements of the Private Placement Warrants are classified as Level 2 due to the use of an observable market quote for a similar asset in an active market.
The FPA’s fair value was estimated using the reconstructed unit price, the net present value of per forward purchase unit commitment, and the forward purchase unit, which is considered to be a Level 3 fair value measurement
.
The following table presents the quantitative information regarding Level 3 fair value measurements:
                 
    
March 31,

2022
    
December 31,

2021
  
Forward Purchase Price (per unit)
    $ 10.00     $ 10.00  
Underlying Asset Price (per share)
    $ 9.77     $ 9.78  
Number of Warrants per unit
      0.25       0.25  
Concluded Unit Value
      9.86       9.95  
Time to Maturity (Years)
      0.41       0.54  
Risk Free Rate
      0.87 %      0.21 % 
 
16
HUDSON EXECUTIVE INVESTMENT CORP. II
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2022
(Unaudited)
 
The following table presents the changes in the fair value of the Level 3 warrant liabilities:
 
 
  
Private

Placement
 
  
Public
 
  
Warrant

Liabilities
 
Fair value as of January 1, 202
2
    $ —        $ —        $ —    
Change in fair value
      —          —          —    
Fair value as of March 31, 2022
    $ —        $ —        $ —    
    
 
 
     
 
 
     
 
 
  
 
 
  
Private

Placement
 
  
Public
 
  
Warrant

Liabilities
 
Fair value as of January 1, 2021
  
$
—  
 
  
$
—  
 
  
$
—  
 
Initial measurement on January 28th, 2021
  
 
5,717,000
 
  
 
7,583,750
 
  
 
13,300,750
 
Change in valuation inputs or other assumptions
  
 
(2,077,600
) 
  
 
(2,708,750
) 
  
 
(4,786,350
) 
Fair value as of March 31, 2021
  
$
3,640,000
 
  
$
4,875,000
 
  
$
8,515,000
 
  
 
 
 
  
 
 
 
  
 
 
 
Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs. There were no changes in levels for the three months ended March 31, 2022, and March 31, 2021.
The following table presents the changes in the fair value of FPA, which utilizes Level 3 measurements:
 
 
  
Forward

Purchase

Agreement

Derivative
 
Fair value as of January 1, 202
2
    $ —    
Change in valuation inputs or other assumptions
      —  
Fair value as of March 31, 2022
    $ —  
    
 
 
  
 
 
  
Forward

Purchase

Agreement

Derivative
 
Fair value as of January 1, 2021
  
$
—  
 
Initial measurement on January 28th, 2021
  
 
16,375
 
Change in valuation inputs or other assumptions
  
 
60,000
 
Fair value as of March 31, 2021
  
$
76,375
 
  
 
 
NOTE 10. SUBSEQUENT EVENTS
The Company evaluated subsequent events and transactions that occurred after March 31, 2022 up to the date that the condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements.
 
17
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to Hudson Executive Investment Corp. II. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to HEIC Sponsor II, LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the condensed financial statements and the notes thereto contained elsewhere in this Quarterly Report (the “Financial Statements”). Capitalized terms used but not otherwise defined herein have the meaning set forth in the Financial Statements. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
Special Note Regarding Forward-Looking Statements
This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this
Form 10-Q
including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s Annual Report on Form
10-K
filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 31, 2022. The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
Overview
We are a blank check company formed under the laws of the State of Delaware on August 18, 2020 for the purpose of effecting the merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). We intend to effectuate our Business Combination using cash from the proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, our capital stock, debt or a combination of cash, stock and debt. Based on our business activities to date, the Company is a “shell company” as defined under the Exchange Act because we have minimal operations and nominal assets consisting almost entirely of cash held in a trust account.
We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.
Results of Operations
We have neither engaged in any operations nor generated any revenues to date. Our only activities from August 18, 2020 (inception) through March 31, 2022 were organizational activities, those necessary to prepare for the Initial Public Offering, described below, and identifying a target company for a Business Combination. We do not expect to generate any operating revenues until after the completion of our Business Combination. We generate
non-operating
income in the form of interest income on marketable securities held in the Trust Account. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.
For the three months ended March 31, 2022, we had a net income of $2,870,152, which consists of the change in the fair value of warrant liabilities and forward purchase agreement derivative asset of $3,305,892 and interest earned on marketable securities held in the Trust Account of $41,197, offset by formation and operating costs of $476,937.
 
18
For the three months ended March 31, 2021, we had net income of $3,688,180, which consists of the change in fair value of warrant liabilities and forward purchase agreement derivative asset of $4,709,975 and interest earned on marketable securities held in the Trust Account of $16,381, offset by formation and operating costs of $1,038,176.
Liquidity and Capital Resources
On January 28, 2021, the Company consummated the Initial Public Offering of 25,000,000 Units, which includes the partial exercise by the underwriter of its over-allotment option in the amount of 2,500,000 Units, at $10.00 per Unit, generating gross proceeds of $250,000,000 which is described in Note 3. Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 4,666,667 Private Placement Warrants at a price of $1.50 per Private Placement Warrant in a private placement to the Sponsor, generating gross proceeds of $7,000,000, which is described in Note 5.
Following the Initial Public Offering, the exercise of the over-allotment option, and the sale of the Private Placement Warrants, a total of $250,000,000 was placed in the Trust Account. We incurred $14,238,064 in Initial Public Offering related costs, including $5,000,000 in cash underwriting fees, $8,750,000 of deferred underwriting fees and $488,064 of other offering costs.
For the three months ended March 31, 2022, cash used in operating activities was $547,528. Net income of $2,870,152 was affected by
non-cash
change in fair value of warrant liabilities and forward purchase agreement derivative asset of $3,305,892, and interest earned on marketable securities held in the Trust Account of $41,197. Changes in operating assets and liabilities used $70,591 of cash for operating activities.
For the three months ended March 31, 2021, cash used in operating activities was $568,243. Net income of $3,688,180 was affected by
non-cash
change in fair value of warrant liabilities and forward purchase agreement derivative asset of $4,709,975, operating costs paid by the Sponsor of $200, operating costs paid through a promissory note of $70,764, interest earned on marketable securities held in the Trust Account of $16,381, and transaction costs incurred in connection with warrant liabilities of $442,366. Changes in operating assets and liabilities used $43,397 of cash for operating activities.
As of March 31, 2022, we had marketable securities held in the Trust Account of $250,076,625 (including $76,625 of interest income and investments consisting of U.S. Treasury Bills/Notes with a maturity of 185 days or less). Interest income on the balance in the Trust Account may be used by us to pay taxes. Through March 31, 2022, we have not withdrawn any interest earned from the Trust Account.
We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less income taxes payable), to complete our Business Combination. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.
As of March 31, 2022, we had cash of $281,975. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.
In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor, or certain of our officers and directors or their affiliates may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we would repay such loaned amounts. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into warrants at a price of $1.50 per warrant, at the option of the lender. The warrants would be identical to the Private Placement Warrants.
If our estimate of the costs of identifying a target business, undertaking
in-depth
due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our Business Combination. Moreover, we may need to obtain additional financing either to complete our Business Combination or because we become obligated to redeem a significant number of our Public Shares upon consummation of our Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination.
Liquidity and Going Concern
As of March 31, 2022, the Company had $281,975 in its operating bank account and a working capital deficit of $388,430. In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsors or an affiliate of the Sponsors, or certain of the Company’s officers and directors, may provide the Company with Working Capital Loans (as defined below) (see Note 5).
The Company intends to complete a Business Combination by January 28, 2023. However, in the absence of a completed Business Combination, the Company may require additional capital. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, suspending the pursuit of a Business Combination. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all.
In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that if the Company is unable to complete a Business Combination by January 28, 2023, then the Company will cease all operations except for the purpose of liquidating. The date for mandatory liquidation and subsequent dissolution raise substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after January 28, 2023.
 
19
Off-Balance
Sheet Arrangements
We have no obligations, assets or liabilities, which would be considered
off-balance
sheet arrangements as of March 31, 2022. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating
off-balance
sheet arrangements. We have not entered into any
off-balance
sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any
non-financial
assets.
Contractual obligations
We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to pay an affiliate of our Sponsor a monthly fee of $10,000 for office space, secretarial and administrative services. We began incurring these fees on January 25, 2021 and will continue to incur these fees monthly until the earlier of the completion of the Business Combination and our liquidation.
The underwriters are entitled to a deferred fee of $0.35 per Unit, or $8,750,000 in the aggregate. The deferred fee will be forfeited by the underwriters solely in the event that the Company fails to complete a Business Combination, subject to the terms of the underwriting agreement.
Critical Accounting Policies
The preparation of condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:
Warrant and FPA Derivatives
The Company accounts for the Warrants and FPA in accordance with the guidance contained in ASC
815-40,
under which the Warrants and FPA do not meet the criteria for equity treatment and must be recorded as assets or liabilities. Accordingly, the Company classifies the Warrants and FPA as an asset or liabilities at their fair value and adjust the Warrants and FPA to fair value at each reporting period. These assets or liabilities are subject tore-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the statements of operations. The fair value of the Public Warrants and Private Placement Warrants has been estimated using the Public Warrants’ quoted market price. The FPA’s fair value was estimated using the reconstructed unit price, the net present value of per forward purchase unit commitment, and the forward purchase unit.
Class A Common Stock Subject to Possible Redemption
We account for our Class A common stock subject to possible redemption in accordance with the guidance in ASC 480. Shares of Class A common stock subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. Our Class A common stock features certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, shares of Class A common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ deficit section of our condensed balance sheets.
Net Income Per Common Share
Net income per common share is computed by dividing net income by the weighted average number of common shares outstanding for the period. Accretion associated with the redeemable shares of Class A common stock is excluded from income per common share as the redemption value approximates fair value.
 
20
Recent Accounting Standards
Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Not required for smaller reporting companies.
Item 4. Controls and Procedures
Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.
Evaluation of Disclosure Controls and Procedures
As required by Rules
13a-15
and
15d-15
under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2022. Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules
13a-15(e)
and
15d-15(e)
under the Exchange Act) were effective. Accordingly, management believes that the financial statements included in this Form
10-Q
present fairly in all material respects our financial position, results of operations, and cash flows for the period presented.
Changes in Internal Control Over Financial Reporting
There was no change in our internal control over financial reporting that occurred during the most recent fiscal quarter covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. All remediation steps were in place at December 31, 2021. The material weakness was remediated during the quarter ended March 31, 2022.
 
21
PART II. OTHER INFORMATION
Facilities
In September 2021, we became a fully remote company. Accordingly, we do not maintain a principal office.
Human Capital Resources
We currently have three executive officers. These individuals are not obligated to devote any specific number of hours to the Company’s matters and intend to devote only as much time as they deem necessary to its affairs. We do not intend to have any
full-time
employees prior to the consummation of a business combination.
Legal Proceedings
There is no material litigation, arbitration or governmental proceeding currently pending against us or any members of our management team in their capacity as such.
Item 1. Legal Proceedings
None.
Item 1A. Risk Factors
Not required for smaller reporting companies.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
On January 28, 2021, we consummated the Initial Public Offering of 25,000,000 Units. The Units were sold at an offering price of $10.00 per unit, generating total gross proceeds of $250,000,000. The securities in the offering were registered under the Securities Act on registration statements on Form
S-1
(Nos.
333-251848
and
333-252417).
The Securities and Exchange Commission declared the registration statements effective on January 25th, 2021.
Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 4,666,667 warrants at a price of $1.50 per Private Placement Warrant in a private placement to HEIC Sponsor II, LLC, generating gross proceeds of $7,000,000. Each Private Placement Warrant is exercisable to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment. The issuance was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.
The Private Placement Warrants are identical to the warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants are not transferable, assignable or salable until after the completion of a Business Combination, subject to certain limited exceptions.
Of the gross proceeds received from the Initial Public Offering, the partial exercise of the over-allotment option and the Private Placement Warrants, an aggregate of $250,000,000 was placed in the Trust Account.
We paid a total of $5,000,000 in cash underwriting discounts and commissions, and $488,064 for other costs and expenses related to the Initial Public Offering. In addition, the underwriters agreed to defer $8,750,000 in underwriting discounts and commissions.
For a description of the use of the proceeds generated in our Initial Public Offering, see Part I, Item 2 of this
Form 10-Q.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
None.
 
22
Item 6. Exhibits
The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report.
 
No.
   
Description of Exhibit
31.1*    Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*    Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1**    Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2**    Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS*    Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCH*    Inline XBRL Taxonomy Extension Schema Document
101.CAL*    Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*    Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*    Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE*    Inline XBRL Taxonomy Extension Presentation Linkbase Document
104*    Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101.INS)
 
*
Filed herewith.
**
Furnished.
 
23
PART III. SIGNATURES
In accordance with the
requirements
of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
   
HUDSON EXECUTIVE INVESTMENT CORP. II
Date: May 16, 2022     By:  
/s/ Douglas G. Bergeron
    Name:   Douglas G. Bergeron
    Title:  
Chief Executive Officer
(Principal Executive Officer)
Date: May 16, 2022     By:  
/s/ Ira Mosberg
    Name:   Ira Mosberg
    Title:  
Chief Financial Officer
(Principal Financial and Accounting Officer)
 
24
Hudson Executive Investm... (NASDAQ:HCII)
Historical Stock Chart
From Jan 2025 to Feb 2025 Click Here for more Hudson Executive Investm... Charts.
Hudson Executive Investm... (NASDAQ:HCII)
Historical Stock Chart
From Feb 2024 to Feb 2025 Click Here for more Hudson Executive Investm... Charts.